Cortex Client AceAge Secures $5 Million in Series A Funding
Last year we wrote about how Cortex client AceAge was selected for Amazon’s inaugural Alexa Accelerator Cohort. Now, we’re proud to announce that AceAge has secured Series A funding!
AceAge’s flagship product, Karie, is a medication dispenser and personal health companion with huge possibilities for care inside the home and institutional settings.
Karie uses preorganized medication pouches prepared by pharmacists to dispense the correct dose of medication, issue reminders to users when it’s the correct time, and send notifications to family or caregivers when a dose of medication is missed.
Karie’s ability to help users navigate complex medication regimens has the potential to vastly improve medication adherence, make life easier for caregivers in long-term care facilities, and reduce the burden on healthcare systems. While at-home advanced care has long been a burgeoning area, the timing for Karie couldn’t be better, with the COVID-19 environment accelerating the shift towards in-home healthcare solutions.
From the whole team at Cortex, we want to give a big congrats to CEO Spencer Waugh and the whole team at AceAge. From the start, AceAge and Cortex spoke the same language. We loved the project so much we decided to invest. We’re thrilled — but not at all surprised — to see the company’s rapid growth.
This $5 million financing round was led by LongLiv Ventures, a member of CK Hutchison Holdings Group, with the participation of a fund led by Bloom Burton.
Head to Newswire for more info about this funding round, and check out our Karie project page for more details about AceAge’s journey to success — as well as Cortex’s industrial design, electronics, firmware, software, and mechanical engineering work on the project.
